Clinical trial
A Phase II Randomized Trial of LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade and Chemotherapy in Participants With Advanced Non-Small Cell Lung Cancer
NCT07890493 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Randomized Trial of LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade and Chemotherapy in Participants With Advanced Non-Small Cell Lung Cancer
- Lead sponsor
- Canadian Cancer Trials Group
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- June 30, 2031
- Enrollment
- 160 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer
Lead sponsor's other trials
Canadian Cancer Trials Group, most recent start first.
+203 more trials See the organization page
Similar trials
Same condition (Carcinoma, Non-Small-Cell Lung) and phase, most recent start first.
+2,324 more trials See the condition page